Proteases (Cysteine)

Proteases (Cysteine)

Proteases, also known as proteolytic enzymes, are enzymes that catalyze the breakdown of proteins by hydrolysis of peptide bonds. By cleaving proteins, proteases are involved in the control of a large number of key physiological processes such as cell-cycle progression, cell proliferation and cell death, DNA replication, tissue remodeling, haemostasis (coagulation), wound healing and the immune response. So far, inappropriate proteolysis has been found to have a major role in cancer as well as cardiovascular, inflammatory, neurodegenerative, bacterial, viral and parasitic diseases. Because excessive proteolysis can be prevented by blocking the appropriate proteases, this area is widely explored by pharmaceutical companies. Their mechanism of action classifies the large family of proteases as either serine, cysteine or threonine proteases (amino-terminal nucleophile hydrolases), or as aspartic, metallo and glutamic proteases (with glutamic proteases being the only subtype not found in mammals so far). Interestingly, the serine and cysteine proteases act directly as nucleophiles to attack the substrate (by generating covalent acyl enzyme intermediates). On the other hand, the aspartyl and zinc proteases activate water molecules as the direct attacking species on the peptide bond. Proteases of the different classes can be further grouped into families on the basis of amino acid sequence comparison, and families can be assembled into clans based on similarities in their three-dimensional structures.A wide variety of cysteine proteases (CPs) exists, that share the common feature of hydrolyzing substrates by direct nucleophilic attack of a deprotonated cysteine residue at the enzyme’s catalytic site. CPs are responsible for many biochemical processes occurring in living organisms and they have been implicated in the development and progression of several diseases that involve abnormal protein turnover. The activity of CPs is regulated among others by their specific inhibitors: cystatins. Mammalian cysteine proteinases fall into two classes: caspases and the papain superfamily comprising the papain family, calpains and bleomycin hydrolases.

Read More
sort-descending
  • Ivachtin
    1375
    The price depends on the options chosen on the product page

    From $60.50

  • Rupintrivir
    1571
    The price depends on the options chosen on the product page

    From $88.00

  • PAC 1
    1743
    The price depends on the options chosen on the product page

    From $88.00

  • MK 0822
    1771
    The price depends on the options chosen on the product page

    From $66.00

  • NS 3694
    1883
    The price depends on the options chosen on the product page

    From $99.00

  • Apoptosis Activator 2
    2006
    The price depends on the options chosen on the product page

    From $82.50

  • MALT1 inhibitor MI-2
    2054
    The price depends on the options chosen on the product page

    From $137.50

  • Balicatib
    2154
    The price depends on the options chosen on the product page

    From $55.00

  • ONO 5334
    2156
    The price depends on the options chosen on the product page

    From $154.00

  • Boc-D-FMK
    2158
    The price depends on the options chosen on the product page

    From $121.00

  • Thioridazine hydrochloride
    2193
    The price depends on the options chosen on the product page

    From $55.00

  • SIC5-6
    3082
    The price depends on the options chosen on the product page

    From $121.00

  • TC11
    3149
    The price depends on the options chosen on the product page

    From $121.00

  • KEA1-97
    3744
    The price depends on the options chosen on the product page

    From $99.00

  • VX-765
    3857
    The price depends on the options chosen on the product page

    From Inquiry

Items 1-15 of 16

More About Proteases (Cysteine)

Proteases, also known as proteolytic enzymes, are enzymes that catalyze the breakdown of proteins by hydrolysis of peptide bonds. By cleaving proteins, proteases are involved in the control of a large number of key physiological processes such as cell-cycle progression, cell proliferation and cell death, DNA replication, tissue remodeling, haemostasis (coagulation), wound healing and the immune response. So far, inappropriate proteolysis has been found to have a major role in cancer as well as cardiovascularinflammatoryneurodegenerativebacterial, viral and parasitic diseases. Because excessive proteolysis can be prevented by blocking the appropriate proteases, this area is widely explored by pharmaceutical companies. Their mechanism of action classifies the large family of proteases as either serinecysteine or threonine proteases (amino-terminal nucleophile hydrolases), or as asparticmetallo and glutamic proteases (with glutamic proteases being the only subtype not found in mammals so far)[1]. Interestingly, the serine and cysteine proteases act directly as nucleophiles to attack the substrate (by generating covalent acyl enzyme intermediates). On the other hand, the aspartyl and zinc proteases activate water molecules as the direct attacking species on the peptide bond. Proteases of the different classes can be further grouped into families on the basis of amino acid sequence comparison, and families can be assembled into clans based on similarities in their three-dimensional structures[2].
A wide variety of cysteine proteases (CPs) exists, that share the common feature of hydrolyzing substrates by direct nucleophilic attack of a deprotonated cysteine residue at the enzyme’s catalytic site. CPs are responsible for many biochemical processes occurring in living organisms and they have been implicated in the development and progression of several diseases that involve abnormal protein turnover. The activity of CPs is regulated among others by their specific inhibitors: cystatins. Mammalian cysteine proteinases fall into two classes: caspases and the papain superfamily comprising the papain family, calpains and bleomycin hydrolases[3].


[1] Targeting proteases: successes, failures and future prospects. Boris Turk. Nature Reviews – Drug Discovery. Volume 5, 2006, 785-799.
[2] Proteases: Multifunctional Enzymes in Life and Disease. C. López-Otín, J.S. Bond. J. Biol. Chem. 2008, 283, 30433-30437.
[3] M. Rzychon, D. Chmiel, J. Stec-Niemczyk. Modes of inhibition of cysteine proteases. Act. Biochim. Pol. 2004, 51, 861-873.

Loading...